Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine and Exercise for Cognitive Decline in Breast Cancer
NCT06727773Phase 2Recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Aug 2025
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in cognitive impairment, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Aug 2025; status: recruiting.
02
Drugs
memantine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT06727773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06727773.